Antonioli L, Blandizzi C, Pacher P, Haskó G (2019) The purinergic system as a pharmacological target for the treatment of immune-mediated inflammatory diseases. Pharmacol Rev 71:345–382. https://doi.org/10.1124/pr.117.014878

Article  PubMed  PubMed Central  CAS  Google Scholar 

Burnstock G (2008) Purinergic signalling and disorders of the central nervous system. Nat Rev Drug Discov 7:575–590. https://doi.org/10.1038/nrd2605

Article  PubMed  CAS  Google Scholar 

Idzko M, Ferrari D, Eltzschig HK (2014) Nucleotide signalling during inflammation. Nature 509:310–317. https://doi.org/10.1038/nature13085

Article  PubMed  PubMed Central  CAS  Google Scholar 

Roberts V, Lu B, Rajakumar S, Cowan PJ, Dwyer KM (2013) The CD39-adenosinergic axis in the pathogenesis of renal ischemia–reperfusion injury. Purinergic Signal 9:135–143. https://doi.org/10.1007/s11302-012-9342-3

Article  PubMed  CAS  Google Scholar 

Kishore BK, Robson SC, Dwyer KM (2018) CD39-adenosinergic axis in renal pathophysiology and therapeutics. Purinergic Signal 14:109–120. https://doi.org/10.1007/s11302-017-9596-x

Article  PubMed  PubMed Central  CAS  Google Scholar 

Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527–552

PubMed  CAS  Google Scholar 

Antonioli L, Fornai M, Blandizzi C, Pacher P, Haskó G (2019) Adenosine signaling and the immune system: when a lot could be too much. Immunol Lett 205:9–15. https://doi.org/10.1016/j.imlet.2018.04.006

Article  PubMed  CAS  Google Scholar 

Vallon V, Osswald H (2009) Adenosine receptors and the kidney. Handb Exp Pharmacol 443–470. https://doi.org/10.1007/978-3-540-89615-9_15.

Vallon V, Mühlbauer B, Osswald H (2006) Adenosine and kidney function. Physiol Rev 86:901–940. https://doi.org/10.1152/physrev.00031.2005

Article  PubMed  CAS  Google Scholar 

Li L, Okusa MD (2010) Macrophages, dendritic cells, and kidney ischemia-reperfusion injury. Semin Nephrol 30:268–277. https://doi.org/10.1016/j.semnephrol.2010.03.005

Article  PubMed  PubMed Central  CAS  Google Scholar 

Eltzschig HK, Eckle T (2011) Ischemia and reperfusion–from mechanism to translation. Nat Med 17:1391–1401. https://doi.org/10.1038/nm.2507

Article  PubMed  CAS  Google Scholar 

Lee HT, Gallos G, Nasr SH, Emala CW (2004) A1 adenosine receptor activation inhibits inflammation, necrosis, and apoptosis after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol JASN 15:102–111. https://doi.org/10.1097/01.asn.0000102474.68613.ae

Article  PubMed  CAS  Google Scholar 

Day Y-J, Huang L, Ye H, Linden J, Okusa MD (2005) Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages. Am J Physiol Renal Physiol 288:F722-731. https://doi.org/10.1152/ajprenal.00378.2004

Article  PubMed  CAS  Google Scholar 

Eckle T, Füllbier L, Wehrmann M, Khoury J, Mittelbronn M, Ibla J, Rosenberger P, Eltzschig HK (2007) Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury. J Immunol Baltim Md 1950(178):8127–8137. https://doi.org/10.4049/jimmunol.178.12.8127

Article  Google Scholar 

Ko J, Rounds S, Lu Q (2020) Sustained adenosine exposure causes endothelial mitochondrial dysfunction via equilibrative nucleoside transporters. Pulm Circ 10:2045894020924994. https://doi.org/10.1177/2045894020924994

Article  PubMed  PubMed Central  CAS  Google Scholar 

Haskó G, Linden J, Cronstein B, Pacher P (2008) Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov 7:759–770. https://doi.org/10.1038/nrd2638

Article  PubMed  PubMed Central  CAS  Google Scholar 

Huang S, Apasov S, Koshiba M, Sitkovsky M (1997) Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood 90:1600–1610

PubMed  CAS  Google Scholar 

Haskó G, Csóka B, Németh ZH, Vizi ES, Pacher P (2009) A2B adenosine receptors in immunity and inflammation. Trends Immunol 30:263–270. https://doi.org/10.1016/j.it.2009.04.001

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cekic C, Linden J (2016) Purinergic regulation of the immune system. Nat Rev Immunol 16:177–192. https://doi.org/10.1038/nri.2016.4

Article  PubMed  CAS  Google Scholar 

Antonioli L, Pacher P, Vizi ES, Haskó G (2013) CD39 and CD73 in immunity and inflammation. Trends Mol Med 19:355–367. https://doi.org/10.1016/j.molmed.2013.03.005

Article  PubMed  PubMed Central  CAS  Google Scholar 

Borea PA, Gessi S, Merighi S, Vincenzi F, Varani K (2018) Pharmacology of adenosine receptors: the state of the art. Physiol Rev 98:1591–1625. https://doi.org/10.1152/physrev.00049.2017

Article  PubMed  CAS  Google Scholar 

Kinsey GR, Sharma R, Okusa MD (2013) Regulatory T cells in AKI. J Am Soc Nephrol JASN 24:1720–1726. https://doi.org/10.1681/ASN.2013050502

Article  PubMed  CAS  Google Scholar 

Sharma R, Kinsey GR (2018) Regulatory T cells in acute and chronic kidney diseases. Am J Physiol Renal Physiol 314:F679–F698. https://doi.org/10.1152/ajprenal.00236.2017

Article  PubMed  CAS  Google Scholar 

Li K, Gong X, Kuang G, Jiang R, Wan J, Wang B (2016) Sesamin protects against renal ischemia reperfusion injury by promoting CD39-adenosine-A2AR signal pathway in mice. Am J Transl Res 8:2245–2254

PubMed  PubMed Central  CAS  Google Scholar 

Linden J, Cekic C (2012) Regulation of lymphocyte function by adenosine. Arterioscler Thromb Vasc Biol 32(9):2097–2103. https://doi.org/10.1161/ATVBAHA.111.226837

Article  PubMed  PubMed Central  CAS  Google Scholar 

Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A, Chen J-F, Enjyoji K, Linden J, Oukka M, Kuchroo VK, Strom TB, Robson SC (2007) Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 204:1257–1265. https://doi.org/10.1084/jem.20062512

Article  PubMed  PubMed Central  CAS  Google Scholar 

Schnurr M, Toy T, Shin A, Hartmann G, Rothenfusser S, Soellner J, Davis ID, Cebon J, Maraskovsky E (2004) Role of adenosine receptors in regulating chemotaxis and cytokine production of plasmacytoid dendritic cells. Blood 103:1391–1397. https://doi.org/10.1182/blood-2003-06-1959

Article  PubMed  CAS  Google Scholar 

Antonioli L, Csóka B, Fornai M, Colucci R, Kókai E, Blandizzi C, Haskó G (2014) Adenosine and inflammation: what’s new on the horizon? Drug Discov Today 19:1051–1068. https://doi.org/10.1016/j.drudis.2014.02.010

Article  PubMed  CAS  Google Scholar 

Effendi WI, Nagano T, Kobayashi K, Nishimura Y (2020) Focusing on adenosine receptors as a potential targeted therapy in human diseases. Cells 9:785. https://doi.org/10.3390/cells9030785